ALGM three-lens brief
Evidence-based stock research on ALGM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +4.59% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +4.59% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 11.3pp over 30 days.
- P/E of 201 — priced for high growth; little margin of safety.
- Analyst mean target $48.85 — 52% above current (13 analysts).
ALGM closed at $32.11 (+4.59%) as of 2026-11-12. Market cap: $5.99B. P/E (trailing) 200.7. Price is below the 50-day MA and below the 200-day MA. Positives: moved +4.59% yesterday.; analyst mean target $48.85 — 52% above current (13 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 11.3pp over 30 days.. Last quarter: Revenue $276.88M, net income $23.26M, free cash flow $133.75M.
Why three lenses on ALGM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALGM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ALGM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALGM brief"></iframe>